Quick Answer
Processa Pharmaceuticals, Inc. reported Total Assets of $7.81 million for the year ending 2025.
- Processa Pharmaceuticals, Inc. showed an increase of +142.0% in Total Assets from 2024 to 2025.
- This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $3.84 million | Q1 2014: $2.91 million | Q2 2014: $2.78 million | Q3 2014: $2.67 million | Q1 2015: $2.54 million | Q2 2015: $877.7 thousand | Q3 2015: $498.1 thousand | Q1 2016: $47.3 thousand | Q2 2016: $43.5 thousand | Q3 2016: $35.2 thousand | Q1 2017: $1.6 thousand | Q2 2017: $1.9 thousand | Q3 2017: $80.3 thousand | Q1 2018: $12.89 million | Q2 2018: $14.44 million | Q3 2018: $13.46 million | Q1 2019: $12.08 million | Q2 2019: $11.31 million | Q3 2019: $10.82 million | Q1 2020: $10.01 million | Q2 2020: $10.01 million | Q3 2020: $9.59 million | Q1 2021: $33.34 million | Q2 2021: $31.14 million | Q3 2021: $29.03 million | Q1 2022: $24.30 million | Q2 2022: $21.66 million | Q3 2022: $18.60 million | Q1 2023: $12.43 million | Q2 2023: $10.09 million | Q3 2023: $8.08 million | Q1 2024: $9.94 million | Q2 2024: $7.60 million | Q3 2024: $4.94 million | Q1 2025: $4.81 million | Q2 2025: $8.18 million | Q3 2025: $7.58 million.
- Over the full 14 years of available data (2012 to 2025), Processa Pharmaceuticals, Inc.'s Total Assets has grown by 101.2%.
- Historical annual values: Fiscal year 2025: $7.81 million | Fiscal year 2024: $3.23 million | Fiscal year 2023: $5.79 million | Fiscal year 2022: $8.62 million | Fiscal year 2021: $26.46 million | Fiscal year 2020: $25.21 million | Fiscal year 2019: $10.88 million | Fiscal year 2018: $12.48 million | Fiscal year 2017: $2.98 million | Fiscal year 2016: $2.36 million | Fiscal year 2015: $104.3 thousand | Fiscal year 2014: $2.55 million | Fiscal year 2013: $2.94 million | Fiscal year 2012: $3.88 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: